IL6 and breast carcinoma: In order to further delineate the relevance of IL-6 and its association with progranulin and sortilin in breast cancer, we analyzed data from Persson et al. in which the PDS model was used to study the secretomic profile of cancer cells grown on patient-specific microenvironments [27].